15 02, 2025 Robrto Montalti et al., Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study adlitterio663392025-02-15T15:19:51+01:00 Mehr erfahren
13 02, 2025 Orhan Gorukmez et al., RNA-based next-generation sequencing approach to non-small cell lung cancer: A single center experience in Turkey adlitterio663392025-02-13T15:18:00+01:00 Mehr erfahren
13 02, 2025 Seda Er Özilhan et al., Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer adlitterio663392025-02-13T15:14:58+01:00 Mehr erfahren
28 01, 2025 Fahmideh Bagrezaei et al., Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study adlitterio663392025-01-28T15:10:34+01:00 Mehr erfahren
27 01, 2025 Elisabetta Maffei et al., Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers adlitterio663392025-01-27T15:07:22+01:00 Mehr erfahren
16 01, 2025 Francesca Pagani et al., Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription adlitterio663392025-01-16T15:01:25+01:00 Mehr erfahren
10 01, 2025 Shooting Cancer Highlights – Periodic focus on regulatory status of new targeted therapies in oncology adlitterio663392025-01-10T15:00:06+01:00 Mehr erfahren
9 01, 2025 Diatech Pharmacogenetics wird an der Medlab-Middle East teilnehmen, die vom 3. bis 6. Februar in Dubai Diatech Pharmacogenetics wird an der Medlab-Middle East teilnehmen, die vom 3. bis 6. Februar in Dubai Nachrichten, Veranstaltungen Diatech Pharmacogenetics wird an der Medlab-Middle East teilnehmen, die vom 3. bis 6. Februar in Dubai adlitterio663392025-01-09T14:53:10+01:00 Mehr erfahren
8 01, 2025 Duhita Mirikar et al., Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR adlitterio663392025-03-07T14:59:27+01:00 Mehr erfahren
2 01, 2025 Jessica Lucchetti et al., Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort adlitterio663392025-01-02T14:43:18+01:00 Mehr erfahren
